期刊文献+

聚合物/表面活性剂二元载体的固体分散体提高普罗布考的溶出度 被引量:4

Improved dissolution of probucol via solid dispersion with polymer/surfactant binary carrier
原文传递
导出
摘要 目的制备以普罗布考为模型药物的固体分散体,以聚合物与表面活性剂为二元载体材料,提高药物溶出度。方法以聚维酮PVP K30、Kollidon VA64、Eudragit E100和Soluplus等聚合物,非离子型表面活性剂Cremophor RH40、D-α-生育酚聚乙二醇1000琥珀酸酯等为载体材料,采用溶剂挥发法制备单一载体或聚合物/表面活性剂二元载体的普罗布考固体分散体。分别在漏槽和非漏槽条件下考察固体分散体的溶出度,差示扫描量热法表征固体分散体中药物结晶状态。结果单一载体普罗布考固体分散体在非漏槽条件下的溶出度均不理想。适宜的聚合物与表面活性剂组合的二元载体固体分散体能明显增加非漏槽条件下的溶出度。热分析结果显示,药物在固体分散体中以非结晶状态存在。非漏槽条件下,VA64/RH40或聚维酮/RH40二元载体固体分散体在介质中形成纳米分散液,溶出度显著增加;而Soluplus/RH40二元载体固体分散体在介质中聚集沉淀,导致溶出度很低。结论聚合物/表面活性剂二元载体有利于提高难溶性药物的溶出,Kollidon VA64/RH40二元载体固体分散体显著提高普罗布考在非漏槽条件的溶出度。 Objective To improve the in vitro dissolution of water-insoluble drug probucol by the solid dispersion made of binary carriers composed of polymers and surfactants. Methods Polymers( PVP K30,Kollidon VA 64,Eudragit E100,and Soluplus,etc) and nonionic surfactants( Cremophor RH40,and TPGS,etc),or polymer-surfactant combinations were used as the single or binary carrier of probucol solid dispersion( PB-SD),and the solvent evaporation method was utilized to prepare drug loaded solid dispersions. In vitro drug dissolution of probucol solid dispersions was tested under sink or non-sink conditions, respectively. The solid dispersions were characterized by DSC method. Results The results showed that the dissolution rate of probucol solid dispersions with single carrier under non-sink condition was relatively low. The dissolution of PB-SD either under sink condition or under non-sink condition was improved by introducing surfactant into the binary carrier and elaborately selecting the combination of polymer and surfactant. DSC analysis indicated that probucol was embedded as non-crystalline state inside the solid dispersions of VA64/RH40 and Soluplus/RH40 binary carriers. Under non-sink condition,VA64/RH40 or PVP K30/RH40 binary carrier solid dispersion could form nano-liquid dispersion after reconstituted in dissolution media and thus improved the dissolution of PB,while Soluplus/RH40 binary carrier solid dispersion aggregated and precipitated out with only about 5% dissolved within 60 min. Conclusions Polymer/surfactant binary carrier is effective in improving the dissolution of water-insoluble drugs. VA64/RH40 binary carrier solid dispersion can greatly improve the dissolution of probucol.
作者 李妍妍 李佳 杨雁 王绍宁 徐晖 LI Yan-yan LI Jia YANG Yan WANG Shao-ning XU Hui(Shenyang Hongqi Pharmaceutical Company Limited, Shenyang 110179, China School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China)
出处 《沈阳药科大学学报》 CSCD 北大核心 2017年第7期535-540,605,共7页 Journal of Shenyang Pharmaceutical University
关键词 固体分散体 普罗布考 溶出度 聚合物/表面活性剂二元载体 solid dispersion probucol dissolution rate polymer/surfactant binary carrier
  • 相关文献

参考文献3

二级参考文献32

  • 1袁菊勇,毛声俊,沈千万,侯世祥,贺英菊.载体联用固体分散技术对丹参酮Ⅱ_A体外溶出的影响[J].中国中药杂志,2009,34(6):685-689. 被引量:9
  • 2宗莉,肖衍宇,陈伶俐.用二元载体固体分散技术提高尼索地平溶出度和调节溶出速率[J].中国药学杂志,2005,40(3):203-206. 被引量:13
  • 3张兆旺.中药药剂学[M].北京:中国中医药出版社,2007.182.
  • 4Lin Rong, Wang Weirong, Liu Juntian, et al. Protective effect of tanshinone 11 A on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism[ J] . J Ethnopharmacol, 2006, 108(2) : 217.
  • 5Yu Xiyong, Lin Shuguang, Zhou Zhiwei, et al. Role of P-glyco- protein in the intestinal absorption of tanshinone Ⅱ A, a major ac tive ingredient in the root of Salvia miltiorrhiza [ J 1. Curr Dru~ / Metab, 2007, 8 : 325.
  • 6Mura P, Faucci M T, Manderioli A, et al . Thermal behavior and dissolution properties of naproxen from binary and ternary sol- id dispersions[J] . Drug Dev Ind Pharm, 1999, 25 (3) :257.
  • 7Hirofumi Takeuchi, Shinsuke Nagira, Hiromitsu Yamamoto, et al. Solid dispersion particles of tolbutamide prepared with fine silica particles by thespray-dryingmethod [ J ]. Powder Technol, 2004, 141: 187.
  • 8Zhao Xia, Liu Xin, Gan Lishe, et al. Preparation and physico- chemical characterizations of tanshinoneⅡ A solid dispersion[ J]. Arch Pharm Res, 2011, 34(6) :949.
  • 9Breitenbach J. Melt extrusion: from process to drug delivery technology [J].Eur JPharm Biopharm, 2002, 54 (2) : 107-117.
  • 10Fu J J, Zhang LL, Guan TT, et al. Stable nimodipine tablets with high bioavailability containing NM-SD prepared by hot-melt extrusion [J]. Powder Technol, 2010, 204 (2-3): 214-221.

共引文献42

同被引文献52

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部